Curtana Pharmaceuticals
is a developer of molecule therapeutics for the treatment of glioblastoma and brain cancers... Read moreCurtana Pharmaceuticals
is a developer of molecule therapeutics for the treatment of glioblastoma and brain cancers... Read more
News
Jul 16, 2021
Contract Pharma
Curtana Pharmaceuticals: Curtana and Catalent Enter Brain Cancer Drug Partnership
Aug 21, 2017
BioSpace
Curtana Pharmaceuticals: Curtana Pharmaceuticals Successfully Completes Pre-IND Submission For CT-179 For The Treatment Of Malignant Gliomas
Aug 16, 2017
Center Watch
Curtana Pharmaceuticals: Curtana granted FDA Orphan designation for gliomas treatment CT-179
Aug 16, 2017
Houston Chronicle
Curtana Pharmaceuticals: Austin pharma company gets FDA approval in its brain cancer fight
Feb 14, 2017
BioPortfolio
Curtana Pharmaceuticals: angelMD Invests in Brain Cancer Treatment Innovator Curtana Pharmaceuticals
Feb 09, 2017
BioSpace
Curtana Pharmaceuticals: <b>angelMD</b> Invests In Brain Cancer Treatment Innovator Curtana Pharmaceuticals
May 31, 2016
BioSpace
Curtana Pharmaceuticals: Curtana Pharmaceuticals Receives Top Honors At The 5th Annual
Nov 25, 2015
SiliconHillsNews
Curtana Pharmaceuticals: Curtana Seeks to Cure Brain Cancer
Nov 18, 2015
BIOSPACE
Curtana Pharmaceuticals: <b>Gary W. Pace</b> Joins Curtana Pharmaceuticals Board Of Directors
Sep 01, 2015
BIOSPACE
Curtana Pharmaceuticals: <b>Martin Simonetti</b> Joins Curtana Pharmaceuticals Board Of Directors
Curtana Pharmaceuticals Competitors
1
2
3
4
5
6
7
8
9
10